Second Sight Medical (EYES) Tops Q3 EPS by 1c

Second Sight Medical (NASDAQ: EYES) reported Q3 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.05 million.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
• Ocean Power Technologies revises fiscal 2026 results after audit